MAP4K4 and neoplasm: We conclude that MAP4K4 couples growth factor signaling to actin cytoskeleton regulation in tumor cells, suggesting that MAP4K4 could be a promising novel target to be evaluated for treating growth factor-induced dissemination of Medulloblastoma tumors of different subgroups and of other human cancers.